Delivery Order SPE2DB20D1004-SPE2DB23FG6M8

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $3.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,059.30, is a delivery order for the supply of 4562353061 - CITALOPRAM HBR 10 MG TABLET 100S. The contract has an ultimate completion date of October 2, 2023 and uses a firm fixed-price pricing type. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,686.71 for the supply of 4560969646 CITALOPRAM HBR 40 MG TABLET 500S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a performance period through May 18, 2023 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,701.15, is for the delivery of 4563063713 CITALOPRAM HBR 40 MG TABLET 100S. The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $3,818.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,841,042 units of the pharmaceutical Citalopram HBR 40 mg tablets, with a completion date of November 17, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award, valued at $6,241.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Citalopram HBR 40 MG Tablets in 500-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,180.78, is for the delivery of 4564690885 CITALOPRAM HBR 40 MG TABLET 500S. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,586,690 tablets of Citalopram HBR 40 mg. The $60,158.76 firm fixed-price contract has an ultimate completion date of October 25, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,101.44 firm fixed-price delivery order is for the supply of 4,560,580 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of April 14, 2023 and was awarded on April 13, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
This federal contract award, valued at $1,469.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,983,231 units of Citalopram HBR 40 mg tablets, a pharmaceutical product, with a completion date of May 19, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded through full and open competition, with no set-aside designation. Amerisourcebergen...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG6M8
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order valued at $3,489.95 for the supply of 4562312518 CITALOPRAM HBR 40 MG TABLET 100S. The award has an ultimate completion date of September 27, 2023 and is a firm fixed-price contract.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a task order placed against this larger DLA IDC contract.

Generated 5/12/25, 9:49 AM